Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Hiasa Ken-ichi Last modified date:2019.06.14



Administration Post
Other
Other
Other


Academic Degree
Ph.D. in Medicine
Country of degree conferring institution (Overseas)
No
Field of Specialization
echocardiography, structure heart disease, venous thrombosis, cardiopulmonary resuscitation
Total Priod of education and research career in the foreign country
00years00months
Research
Research Interests
  • Structure heart disease, cardiopulmonary resuscitation, venous thrombosis, anticoagulation, heart failure, echocardiography
    keyword : Structure heart disease, echocardiography, Venous thrombosis, anticoagulation, cardiopulmonary resuscitation
    2000.04~2020.03.
Academic Activities
Papers
1. Hiasa K, Ishibashi M, Otani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, Egashira K, Gene Transfer of Stromal Cell-Derived Factor-1α Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor / Endothelial Nitric Oxide Synthase-Related Pathway: Next-Generation Chemokine Therapy for Therapeutic Neovascularizaiton, Circulation , 10.1161/01.CIR.0000128213.96779.61, 109, 20, 2454-2461, 2004:109(20): 2454-2461, 2004.05.
2. Hiasa K, Egashira K, Kitamoto S, Ishibashi M, Inoue S, Ni w, Zhao W, Nagata S, Katoh M, Sata M, Takeshita A, Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor, Basic Research in Cardiology , 10.1007/s00395-004-0456-9, 99, 3, 165-172, 2004; 99(3): 165-172, 2004.02.
3. Ken-ichi Hiasa, Masao Takemoto, Ryuichi Matsukawa, Tetsuya Matoba, Takeshi Kuga, Kenji Sunagawa, Chest Pain without Significant Coronary Stenosis after Implantation of Sirolimus-Eluting Stents, Internal Medicine, 48: 1-20, 2009, 2009.02.
4. Ken-ichi Hiasa, George Koike, Akiko Chishaki, Hideo Tada, Kenji Sunagawa, A case report of therapeutic hypothermia, which could improve the neurological outcome after cardiac arrest., Heart, Vol.38 Supplement 3, 5-9, 2006, 2006.06.
Presentations
1. Hiasa Ken-ichi, Yasuhiro Sezutsu, Ichiro Sakamoto, Keiji Oi, Yasushi Mukai, Ide Tomomi, Taiki Higo, Kenji Sunagawa, The impact of FE-K (a possible marker of RAAS activation or GFR reduction) on the survival rate of heart failure patients treated with tolvaptan, Japanese Circulation Society, 2015.04.
Educational
Other Educational Activities
  • 2019.06.
  • 2019.04.
  • 2012.04.